Literature DB >> 26670166

The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications.

Marco Cosentino1, Franca Marino2.   

Abstract

The Second Insubria Autumn School on Neuroimmune Pharmacology was held at the University of Insubria in Varese (Italy) in November 16th-20th 2015, under the auspices of the Society on NeuroImmune Pharmacology, the Italian Society of Pharmacology, and the Italian Association for Neuroimmunology. The School was dedicated to the repurposing of established drugs for novel indications, considering the enormous opportunities for drug repositioning provided by the prominent innovative and interdisciplinary approaches peculiar to neuroimmune pharmacology. More than 40 graduate students and postdoctoral fellows from 12 european universities, research institutes and hospitals attended the School, and lectures were given by 20 internationally acknowledged experts in the fields of basic and clinical neurosciences, immunology, and pharmacology. A poster session provided young researchers the opportunity to present their results, and the best poster was given the Journal of Neuroimmune Pharmacology Young Investigator Award.

Keywords:  Drug repurposing; Insubria Autumn School; Neuroimmune pharmacology

Year:  2015        PMID: 26670166     DOI: 10.1007/s11481-015-9649-2

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  10 in total

Review 1.  Drug repositioning: identifying and developing new uses for existing drugs.

Authors:  Ted T Ashburn; Karl B Thor
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

2.  Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease.

Authors:  Natasa Kustrimovic; Emanuela Rasini; Massimiliano Legnaro; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-29       Impact factor: 4.147

Review 3.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

4.  The first Insubria autumn school on neuroimmunopharmacology: challenging paradigms beyond boundaries.

Authors:  Marco Cosentino; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-12       Impact factor: 4.147

5.  Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia.

Authors:  Chandrani Sarkar; Debanjan Chakroborty; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Int J Cancer       Date:  2015-01-07       Impact factor: 7.396

Review 6.  Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.

Authors:  Katherine E Olson; Howard E Gendelman
Journal:  Curr Opin Pharmacol       Date:  2015-11-11       Impact factor: 5.547

Review 7.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

Review 8.  Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines.

Authors:  Chandrani Sarkar; Debanjan Chakroborty; Sujit Basu
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-11       Impact factor: 4.147

Review 9.  Neural and immune mechanisms in the pathogenesis of Parkinson's disease.

Authors:  Fabio Blandini
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-03       Impact factor: 4.147

Review 10.  Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives.

Authors:  Marco Cosentino; Franca Marino; Georges J M Maestroni
Journal:  Front Cell Neurosci       Date:  2015-08-05       Impact factor: 5.505

  10 in total
  2 in total

Review 1.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

Review 2.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.